These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11702957)
1. Prevalence of complementary and alternative medicine use in cancer patients. Bernstein BJ; Grasso T Oncology (Williston Park); 2001 Oct; 15(10):1267-72; discussion 1272-8, 1283. PubMed ID: 11702957 [TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. Dy GK; Bekele L; Hanson LJ; Furth A; Mandrekar S; Sloan JA; Adjei AA J Clin Oncol; 2004 Dec; 22(23):4810-5. PubMed ID: 15570083 [TBL] [Abstract][Full Text] [Related]
3. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. Ezeome ER; Anarado AN BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665 [TBL] [Abstract][Full Text] [Related]
4. Use of complementary and alternative medicine among cancer patients in Israel. Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105 [TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195 [TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative medications consumed by renal patients in southern Germany. Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442 [TBL] [Abstract][Full Text] [Related]
7. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway. Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678 [TBL] [Abstract][Full Text] [Related]
8. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. Chrystal K; Allan S; Forgeson G; Isaacs R N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420 [TBL] [Abstract][Full Text] [Related]
9. Complementary treatments for tobacco cessation: a survey. Sood A; Ebbert JO; Sood R; Stevens SR Nicotine Tob Res; 2006 Dec; 8(6):767-71. PubMed ID: 17132524 [TBL] [Abstract][Full Text] [Related]
10. Use of alternative and complementary therapies in children with cancer. Martel D; Bussières JF; Théorêt Y; Lebel D; Kish S; Moghrabi A; Laurier C Pediatr Blood Cancer; 2005 Jun; 44(7):660-8. PubMed ID: 15714446 [TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine use during early pregnancy. Pallivalappila AR; Stewart D; Shetty A; Pande B; Singh R; Mclay JS Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():251-5. PubMed ID: 25190299 [TBL] [Abstract][Full Text] [Related]
12. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Swarup AB; Barrett W; Jazieh AR Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781 [TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine use among health plan members. A cross-sectional survey. Gray CM; Tan AW; Pronk NP; O'Connor PJ Eff Clin Pract; 2002; 5(1):17-22. PubMed ID: 11878283 [TBL] [Abstract][Full Text] [Related]
14. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer. Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594 [TBL] [Abstract][Full Text] [Related]
15. Use of complementary and alternative medicine for eye-related diseases and conditions. Bromfield SG; McGwin G Curr Eye Res; 2013 Dec; 38(12):1283-7. PubMed ID: 23972126 [TBL] [Abstract][Full Text] [Related]
16. Use of complementary and alternative medicine in patients with cancer: a UK survey. Scott JA; Kearney N; Hummerston S; Molassiotis A Eur J Oncol Nurs; 2005 Jun; 9(2):131-7. PubMed ID: 15944106 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Naing A; Stephen SK; Frenkel M; Chandhasin C; Hong DS; Lei X; Falchook G; Wheler JJ; Fu S; Kurzrock R Cancer; 2011 Nov; 117(22):5142-50. PubMed ID: 21538342 [TBL] [Abstract][Full Text] [Related]
18. Complementary and alternative medicine (CAM) among hospitalised patients: reported use of CAM and reasons for use, CAM preferred during hospitalisation, and the socio-demographic determinants of CAM users. Shorofi SA Complement Ther Clin Pract; 2011 Nov; 17(4):199-205. PubMed ID: 21982133 [TBL] [Abstract][Full Text] [Related]
19. Use of complementary medicine by adult patients participating in cancer clinical trials. Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691 [TBL] [Abstract][Full Text] [Related]
20. Complementary and alternative medicine use among patients undergoing otolaryngologic surgery. Shakeel M; Newton JR; Ah-See KW J Otolaryngol Head Neck Surg; 2009 Jun; 38(3):355-61. PubMed ID: 19476768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]